The company's principal activities are to develop and license transdermal drug delivery compounds and systems intended to promote the delivery of drugs from the surface of the skin into the skin or the bloodstream. It develops pharmaceutical products for commercial use by applying sepa(R) (soft enhancer of percutaneous absorption), one of its patented topical drug delivery systems. It has also developed a series of new low molecular weight polymers for cosmetic use and topical delivery. The company operates only in domestic market.
